NCT03682068 2026-02-03
NILE
AstraZeneca
Phase 3 Active not recruiting
Clinical Trials
4 trialsNCT02516241 2026-01-28
Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer
AstraZeneca
Phase 3 Active not recruiting
NCT04960709 2025-12-19
VOLGA
AstraZeneca
Phase 3 Active not recruiting
NCT03288532 2020-09-07
RAMPART
University College, London
Phase 3 Recruiting